Most evidence points to inhibitory AhR–ERα crosstalk, in which the activation of the AhR blocks ERα signaling, which in turn stops breast and endometrial cancer cells from proliferating and growing into mammary tumors [6]. This evidence concerns the gene ESR1 and endometrial cancer.